Skip to main content
. Author manuscript; available in PMC: 2024 Mar 1.
Published in final edited form as: Environ Toxicol Pharmacol. 2023 Jan 5;98:104062. doi: 10.1016/j.etap.2023.104062

Table 4.

Association of PFOS with total cholesterol is dependent on extent of lipid lowering

Non-responders

Covariate
Estimated regression coefficient Standard Error p-value
Intercept 196.0 27.2 <.001
PFOSpost (log) −0.226 3.20 0.944
Sex 17.4 6.21 0.006
Age 0.337 0.200 0.094
Education level −0.278 0.958 0.772
Race −1.39 4.63 0.764
BMIpost −0.326 0.359 0.366
Smoking history −4.83 3.43 0.160
Years living in current county 0.278 0.147 0.061
Responders

Covariate
Estimated regression coefficient Standard Error p-value
Intercept 151 32.8 <.001
PFOSpost (log) 9.57 3.02 0.002
Sex 14.2 6.14 0.022
Age 0.163 0.223 0.467
Education level 0.243 0.995 0.807
Race −5.38 5.94 0.367
BMIpost 0.009 0.405 0.983
Smoking history −1.38 3.07 0.653
Years living in current county 0.009 0.157 0.954
*

Responders lost >6 mg/dL total cholesterol (median loss). (n=171 non responders, n=162 responders).

BMI: Body mass index. PFOS= Perfluorooctanesulfonic acid

The estimates above define a formula for the prediction of total cholesterol in subject’s post intervention.

For variable “sex”, 0=male. 1=female; For variable “Race”, 1=African American. 2=Caucasian. 3=Asian. 4=Hispanic/Latino. 5=American Indian/Alaskan Native. 6= Native Hawaiian/other Pacific. For variable “Smoking history”, 1=current smoker. 2=Stopped within 1 year. 3=stopped more than 1 year ago. 4=never smoked.